Speaker illustration

Professor Juan Tamargo

Complutense University of Madrid, Madrid (Spain)

Member of:

European Society of Cardiology

Juan Tamargo is Professor of Pharmacology in the School of Medicine of the University Complutense of Madrid (Spain). He graduated as physician, obtained a PhD in Pharmacology and a master’s degree in clinical pharmacology. He completed his postgraduate training in the New York Upstate and Downstate Medical Centres (US) and the Universität des Saarlandes (Germany). He is Member of the Royal National Academies of Pharmacy and Medicine and of the Spanish Institute. His primary research interest is cardiovascular pharmacology, with a focus on cardiac electrophysiology and arrhythmias. He is an editorial board member for: Basic & Clinical Pharmacology & Toxicology, Cardiovascular Drugs and Therapy, European Cardiology Review, Frontiers in Physiology (Cardiac electrophysiology), Frontiers in Drug safety and Regulation, and J. Pharmacological Sciences. Associated Editor of the International Journal of Cardiology and European Heart Journal-Cardiovascular Pharmacotherapy.

Challenges in antiarrhythmic pharmacotherapy

Event: EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy

Topic: Cardiovascular Pharmacotherapy

Session type: Teaching Course

Thumbnail

Cardiovascular Pharmacotherapy in Women

Event: EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy

Topic: Cardiovascular Pharmacotherapy

Session type: Teaching Course

Thumbnail

The new era of SGLT2 Inhibitors in Cardiovascular Disease: beyond glucose control

Event: EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy

Topic: Cardiovascular Pharmacotherapy

Session type: Teaching Course

Thumbnail

Oral anticoagulation in patients with venous thromboembolism or left ventricular thrombus

Event: ESC Congress 2023

Topic: Anticoagulants

Session type: Moderated ePosters

Thumbnail

Oral anticoagulation in patients with atrial fibrillation

Event: ESC Congress 2023

Topic: Anticoagulants

Session type: Moderated ePosters

Thumbnail

Strategies to improve cardiovascular pharmacotherapy in older people

Event: Pharmacotherapy in Older People (POP) 2023

Topic: Pharmacology and Pharmacotherapy

Session type: Symposium

Thumbnail

Welcome address

Event: Pharmacotherapy in Older People (POP) 2023

Topic: Working Groups

Session type: Special Event

Thumbnail

Heart failure with reduced ejection fraction (HFrEF) 1

Event: Heart Failure 2023

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session type: Moderated ePosters

Thumbnail

Heart failure with reduced ejection fraction (HFrEF) 3

Event: Heart Failure 2023

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session type: Moderated ePosters

Thumbnail

How to design and run a clinical trial

Event: All About Clinical Trials (AACT)

Topic: Trial Design

Session type: Teaching Course

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb